Real-World Data Confirms Upadacitinib’s Efficacy in Treating Moderate to Severe Atopic Dermatitis
At the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference in Nashville, Tennessee, new late-breaking data from the CorEvitas Atopic Dermatitis (AD) ...